- Antibodies
- New
- Biological Process >
- Cellular Compartment >
- Disease >
- Molecular Function >
- Pathway Biocarta >
- Pathway KEGG >
- Pathway Panther >
- Tissue >
- Tag
- Peptides
- Biological Process >
- Cellular Compartment >
- Disease >
- Molecular Function >
- Pathway Biocarta >
- Pathway KEGG >
- Pathway Panther >
- Tissue >
- Amino Acids
- Tag
- Biological Process >
- Proteins
- RNAi
- FL cDNA Clones
- Cell/Tissues/Lysates
BMPR1A predesign siRNASynthetic RNA
| Country | United States
Ordering Information
|
|||
|---|---|---|---|---|
| Catalog # | Size | Availability | Price | |
| RI10618 | 5 OD 400 ul | 13-15 days | $ 110.00 | DISCONTINED INQUIRE CLICK INQUIRE Add to cart |
- Specification
- Citiations : 0
- Reviews
- Protocols
- Backgrounds
BMPR1A predesign siRNA - Additional info | |
| Gene ID | 657 |
| Gene Symbol | BMPR1A |
| Other Names ALK3, SKR5, CD292, ACVRLK3, 10q23del, BMPR1A | |
| Format HPLC purified siRNA is supplied as a dried pellet in nmol quantities. | |
| Storage Maintain refrigerated at 2-8°C for up to one week. For long term storage store at -20°C. | |
| Precautions This product is for research use only. Not for use in diagnostic or therapeutic procedures. | |
BMPR1A predesign siRNA - Related products
AP2004a: BMPR1A Antibody (N-term)
AP2004b: BMPR1A Antibody (C-term)
AP2004c: BMPR1A Antibody (N-term K36)
AP2004d: BMPR1A Antibody (Center C180)
AP2004e: BMPR1A Antibody (N-term)
AP2004f: BMPR1A Antibody (N-term)
RI10618: BMPR1A predesign siRNA
DC05829: Human BMPR1A cDNA Clone
LY11707a: BMPR1A Over-expression Lysate
BP2004a: BMPR1A Antibody (N-term) Blocking Peptide
BP2004b: BMPR1A Antibody (C-term) Blocking Peptide
BP2004c: BMPR1A Antibody (N-term K36) Blocking Peptide
BP2004d: BMPR1A Antibody (Center C180) Blocking Peptide
BP2004e: BMPR1A Antibody (N-term) Blocking Peptide
Abgent welcomes feedback from its customers.
If you have used an Abgent product and would like to share how it has performed, please click on the
"Submit Review" button and provide the requested information. Our staff will examine and post your
review and contact you if needed.
If you have any additional inquiries please email technical services at tech@abgent.com.
Thank you for your support.
Provided below are standard protocols that you may find useful for product applications.
BACKGROUND
The bone morphogenetic protein (BMP) receptors are a family of transmembrane serine/threonine kinases that include the type I receptors BMPR1A and BMPR1B and the type II receptor BMPR2. These receptors are also closely related to the activin receptors, ACVR1 and ACVR2. The ligands of these receptors are members of the TGF-beta superfamily. TGF-betas and activins transduce their signals through the formation of heteromeric complexes with 2 different types of serine (threonine) kinase receptors: type I receptors of about 50-55 kD and type II receptors of about 70-80 kD. Type II receptors bind ligands in the absence of type I receptors, but they require their respective type I receptors for signaling, whereas type I receptors require their respective type II receptors for ligand binding.
REFERENCES
Genetic risk factors for hepatopulmonary syndrome in patients with advanced liver disease. Roberts KE, et al. Gastroenterology, 2010 Jul. PMID 20346360. Germline bone morphogenesis protein receptor 1A mutation causes colorectal tumorigenesis in hereditary mixed polyposis syndrome. Cheah PY, et al. Am J Gastroenterol, 2009 Dec. PMID 19773747. Adipose tissue expression and genetic variants of the bone morphogenetic protein receptor 1A gene (BMPR1A) are associated with human obesity. B?ttcher Y, et al. Diabetes, 2009 Sep. PMID 19502417. Pediatric juvenile polyposis syndromes: an update. Huang SC, et al. Curr Gastroenterol Rep, 2009 Jun. PMID 19463221. High-density association study of 383 candidate genes for volumetric BMD at the femoral neck and lumbar spine among older men. Yerges LM, et al. J Bone Miner Res, 2009 Dec. PMID 19453261.